Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs.

Tibau A, Bedard PL, Srikanthan A, Ethier JL, Vera-Badillo FE, Templeton AJ, Ocaña A, Seruga B, Barnadas A, Amir E.

J Clin Oncol. 2015 Jan 1;33(1):100-6. doi: 10.1200/JCO.2014.57.8898. Epub 2014 Nov 10.

PMID:
25385736
2.

Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.

Mitchell AP, Basch EM, Dusetzina SB.

JAMA Oncol. 2016 Dec 1;2(12):1628-1631. doi: 10.1001/jamaoncol.2016.2710.

PMID:
27561170
3.

Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.

Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD.

JAMA. 2011 Mar 9;305(10):1008-17. doi: 10.1001/jama.2011.257. Review.

PMID:
21386079
4.

Conflicts of interest ethics: silencing expertise in the development of international clinical practice guidelines.

Jones DJ, Barkun AN, Lu Y, Enns R, Sinclair P, Martel M, Gralnek I, Bardou M, Kuipers EJ, Sung J; International Consensus Upper Gastrointestinal Bleeding Conference Group.

Ann Intern Med. 2012 Jun 5;156(11):809-16, W-283. doi: 10.7326/0003-4819-156-11-201206050-00008.

PMID:
22665816
5.

Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Choudhry NK, Stelfox HT, Detsky AS.

JAMA. 2002 Feb 6;287(5):612-7.

PMID:
11829700
6.

Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.

Shnier A, Lexchin J, Romero M, Brown K.

BMC Health Serv Res. 2016 Aug 15;16(a):383. doi: 10.1186/s12913-016-1646-5.

7.

Guidelines, editors, pharma and the biological paradigm shift.

Singh AR, Singh SA.

Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.

8.

Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study.

Bindslev JB, Schroll J, Gøtzsche PC, Lundh A.

BMC Med Ethics. 2013 May 3;14:19. doi: 10.1186/1472-6939-14-19.

9.

Conflict of interest reporting in otolaryngology clinical practice guidelines.

Sun GH.

Otolaryngol Head Neck Surg. 2013 Aug;149(2):187-91. doi: 10.1177/0194599813490894. Epub 2013 May 23. Review.

PMID:
23702973
10.

Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.

Checketts JX, Sims MT, Vassar M.

JAMA Dermatol. 2017 Dec 1;153(12):1229-1235. doi: 10.1001/jamadermatol.2017.3109.

PMID:
29049553
11.

Guideline funding and conflicts of interest: article 4 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Boyd EA, Akl EA, Baumann M, Curtis JR, Field MJ, Jaeschke R, Osborne M, Schünemann HJ; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):234-42. doi: 10.1513/pats.201208-057ST. Review.

PMID:
23256165
12.

Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.

Riechelmann RP, Wang L, O'Carroll A, Krzyzanowska MK.

J Clin Oncol. 2007 Oct 10;25(29):4642-7.

PMID:
17925561
13.
14.

Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines.

Lu Y, Jones DJ, Sharara N, Kaltenbach T, Laine L, McQuaid K, Soetikno R, Subramanian V, Barkun A.

PLoS One. 2017 Aug 25;12(8):e0182856. doi: 10.1371/journal.pone.0182856. eCollection 2017.

15.

Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.

Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO.

Neurology. 2008 Jul 1;71(1):57-63. doi: 10.1212/01.wnl.0000316319.19159.c3.

PMID:
18591506
16.

Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.

Pang WK, Yeter KC, Torralba KD, Spencer HJ, Khan NA.

Int J Rheum Dis. 2015 Jul;18(6):606-15. doi: 10.1111/1756-185X.12607. Epub 2015 May 27.

PMID:
26012523
17.

Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.

Rose SL, Krzyzanowska MK, Joffe S.

J Clin Oncol. 2010 Mar 10;28(8):1316-21. doi: 10.1200/JCO.2008.21.6606. Epub 2010 Jan 11.

18.

Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review.

Wang AT, McCoy CP, Murad MH, Montori VM.

BMJ. 2010 Mar 18;340:c1344. doi: 10.1136/bmj.c1344. Review.

19.

Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials.

Aneja A, Esquitin R, Shah K, Iyengar R, Nisenbaum R, Melo M, Matthewkutty S, Sethi SS, Mamdani M, Farkouh ME.

J Am Coll Cardiol. 2013 Mar 19;61(11):1137-43. doi: 10.1016/j.jacc.2012.10.056. Epub 2013 Feb 6. Review.

20.

Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.

Norris SL, Holmer HK, Ogden LA, Burda BU, Fu R.

PLoS One. 2013 Oct 14;8(10):e75284. doi: 10.1371/journal.pone.0075284. eCollection 2013.

Supplemental Content

Support Center